arrow
J

Jeong Uk Lim

Department of Investigational Cancer Therapeutics
H指数:20
被引数:1,710

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors
2026-07-300
OA
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD Anderson参与早期临床试验的晚期非小细胞肺癌患者中的治疗效果

2026-01-130
OAAI
Development of a three-dimensional airway organoid-pillar dish (3D AO-PD) platform for particulate matter-induced airway toxicity analysis

开发一种用于颗粒物诱导气道毒性分析的气道上皮类器官-柱状培养皿(3D AO-PD)平台

2025-11-200
OAAI
Prognostic factors affecting mortality in elderly, low body mass index, and poor performance status groups with lung cancer: analysis of the 2016 Korean Association of Lung Cancer Registry (KALC-R) database

影响老年、低体重指数及较差体能状态肺癌患者死亡率的预后因素:韩国肺癌登记系统(KALC-R)2016年数据库分析

2025-09-300
PRE
Comparison of metastasis and treatment patterns among different histopathologic types of lung cancer: analysis of 6 years of nationwide lung cancer cohort data in Korea
2025-02-010
OAAI
Factors Associated with Postoperative Recurrence in Stage I to IIIA Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: Analysis of Korean National Population Data

表皮生长因子受体突变相关的Ⅰ期至ⅢA期非小细胞肺癌术后复发相关因素:基于韩国全国人口数据的分析

2025-01-151
OA
U-Shape Pillar Strip for 3D Cell-Lumped Organoid Model (3D-COM) Mimicking Lung Cancer Hypoxia Conditions in High-Throughput Screening (HTS)
2024-06-100
PRE
Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion
2024-05-210
OAAI
Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (vol 42, 309, 2023)
2023-12-060
OAAI